Oppenheimer analyst Michael Wiederhorn raised the price target on HCA Holdings (NYSE: HCA) to $150.00 (from $142.00) while maintaining a Outperform rating.

Analyst PT Change

HCA Holdings (HCA) PT Raised to $175 at Leerink PartnersJanuary 30, 2019 7:31 AM HCA Holdings (HCA) PT Raised to $128 at Morgan StanleyJanuary 30, 2019 7:21 AM HCA Holdings (HCA) PT Raised to $153 at Mizuho Securities Following 4Q January 30, 2019 7:19 AM HCA Holdings (HCA) PT Raised to $158 at CitiJanuary 30, 2019 6:53 AM HCA Holdings (HCA) PT Raised to $152 at StephensJanuary 30, 2019 6:35 AM HCA Holdings (HCA) PT Raised to $164 at UBSJanuary 30, 2019 6:03 AM HCA Holdings (HCA) PT Raised to $155 at BarclaysJanuary 30, 2019 4:16 AM HCA Holdings (HCA) PT Raised to $160 at Deutsche BankJanuary 29, 2019 5:27 PM HCA Holdings (HCA) PT Raised to $153 at Mizuho SecuritiesJanuary 29, 2019 3:56 PM HCA Holdings (HCA) PT Raised to $160 at Wells FargoJanuary 29, 2019 3:26 PM Form 8-K HCA Healthcare, Inc. For: Jan 29January 29, 2019 9:08 AM HCA Holdings (HCA) Raises Quarterly Dividend 14.3% to $0.40; Approves $2B BuybackJanuary 29, 2019 8:33 AM HCA Holdings (HCA) Tops Q4 EPS by 43c, Offers FY GuidanceJanuary 29, 2019 8:32 AM HCA Reports Fourth Quarter 2018 Results and Provides 2019 GuidanceJanuary 29, 2019 8:30 AM